Clinical research and health tech companies Medidata and Cogstate are joining forces to speed up trials and improve outcomes measurement across diseases of the central nervous system, the partners ...
Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of John Harrison as Clinical Vice President. As drug developers face growing demand for ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience ...
PHILADELPHIA, June 29, 2021 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, today announced a new acceleration program that reduces study setup timelines ...
Immunogenicity of sipuleucel-T (Sip-T) in abiraterone (Abi)/enzalutamide (Enz) sensitive and resistant metastatic castrate-resistant prostate cancer (mCRPC). Validation of the association of RECIST ...
Onsite tops 20 CNS trials, delivering quality ocular endpoint protection via point-of-need mobile vision clinics. 95+ NPS & 100% timelines met.
CNS metastases in EGFR-mutant NSCLC are prevalent and worsen prognosis, especially with acquired progression during treatment. Amivantamab plus lazertinib shows promising CNS activity, but current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback